Patents Assigned to Progeneer Inc.
  • Patent number: 11814662
    Abstract: This application provides methods and compositions related to constructing nucleic acid hydrogels (e.g., RNA hydrogels) having repetitive monomer units, each monomer unit includes one or more G-quadruplex sequences. These G-quadruplex sequences cross-link the nucleic acid concatemer such that it self-assembles into a hydrogel under appropriate conditions. In some embodiments, each monomeric unit of the nucleic acid concatemer comprises a coding sequence for polypeptide of interest; and the nucleic acid hydrogel formed by the nucleic acid concatemer can be used for expressing the polypeptide in high quantities. In some embodiments, at least two RNA concatemers comprising G-quadruplex sequences are produced, one further comprising a spacer and the other further comprising a sequence encoding a polypeptide of interest. These two RNA concatemers are combined and self assembled to form a single, wideband RNA hydrogel.
    Type: Grant
    Filed: October 29, 2020
    Date of Patent: November 14, 2023
    Assignee: Progeneer, Inc.
    Inventors: So Yeon Ahn, Srivithya Vellampatti Krishnamoorthy, Soong Ho Um, Sung Oh, Seung Won Shin
  • Publication number: 20230100429
    Abstract: The present invention relates to: a lyophilized preparation of a pathogen cell wall skeleton, the preparation containing the pathogen cell wall skeleton as an active ingredient; various live-pathogen-mimetic nanoparticles produced by using the lyophilized preparation and antagonists of toll-like receptor 7 or 8 which can induce the efficacy of the live pathogen; a use thereof; and a production method thereof.
    Type: Application
    Filed: February 26, 2021
    Publication date: March 30, 2023
    Applicant: Progeneer Inc.
    Inventors: Yong Taik LIM, Sang Nam LEE